Follow
Maria Del Pilar Estevez Diz
Maria Del Pilar Estevez Diz
Medica, Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira ICESP
Verified email at hc.fm.usp.br
Title
Cited by
Cited by
Year
Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial
J Pinheiro de Almeida, JL Vincent, FR Barbosa Gomes Galas, ...
Anesthesiology 122 (1), 29-38, 2015
2512015
Diretrizes para detecção precoce do câncer de mama no Brasil. II-Novas recomendações nacionais, principais evidências e controvérsias
A Migowski, GA Silva, MBK Dias, MDPE Diz, DR Sant’Ana, P Nadanovsky
Cadernos de Saúde Pública 34, e00074817, 2018
1752018
Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
RR da Cunha Colombo Bonadio, RN Fogace, VC Miranda, MPE Diz
Clinics 73, e450s, 2018
1362018
Palliative care in the global setting: ASCO resource-stratified practice guideline
H Osman, S Shrestha, S Temin, ZV Ali, RA Corvera, HD Ddungu, ...
Journal of global oncology 4, 1-24, 2018
1242018
I Diretriz Brasileira de cardio-oncologia da Sociedade Brasileira de Cardiologia
R Kalil Filho, LA Hajjar, F Bacal, PM Hoff, MP Diz, FRBG Galas
Arquivos brasileiros de cardiologia 96, 01-52, 2011
1212011
Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial
FS Bergamin, JP Almeida, G Landoni, FRBG Galas, JT Fukushima, ...
Critical care medicine 45 (5), 766-773, 2017
1162017
Guidelines for early detection of breast cancer in Brazil. II-New national recommendations, main evidence, and controversies
A Migowski, MBK Dias, MDPE Diz, DR Sant’Ana, P Nadanovsky
Cadernos de saude publica 34, e00074817, 2018
1022018
Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: safety and effectiveness
V da Costa Miranda, ÂB de Souza Fęde, CH Dos Anjos, JR da Silva, ...
Gynecologic oncology 132 (2), 287-291, 2014
982014
A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant …
AM Oza, M Estevez-Diz, EM Grischke, M Hall, F Marmé, D Provencher, ...
Clinical Cancer Research 26 (18), 4767-4776, 2020
832020
Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations
M Lambertini, L Ameye, AS Hamy, A Zingarello, PD Poorvu, E Carrasco, ...
Journal of Clinical Oncology 38 (26), 3012-3023, 2020
822020
Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation versus chemoradiation for locally advanced cervical cancer: a randomized phase II trial
SCS da Costa, RC Bonadio, FCG Gabrielli, AS Aranha, MLN Dias Genta, ...
Journal of Clinical Oncology 37 (33), 3124-3131, 2019
762019
Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
S Maistro, N Teixeira, G Encinas, MLH Katayama, VDT Niewiadonski, ...
BMC cancer 16, 1-8, 2016
722016
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients
MP Freire, LC Pierrotti, HHC Filho, KY Ibrahim, A Magri, PR Bonazzi, ...
European Journal of Clinical Microbiology & Infectious Diseases 34, 277-286, 2015
702015
Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer
DM O'Malley, A Oaknin, BJ Monk, F Selle, C Rojas, L Gladieff, D Berton, ...
Gynecologic oncology 163 (2), 274-280, 2021
692021
Consenso brasileiro sobre manejo da dor relacionada ao câncer
EG Wiermann, MPE Diz, R Caponero, PSM Lages, CZS Araújo, ...
RevBrasOncolClin 10 (38), 2014
562014
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
I Vergote, A Gonzalez-Martin, D Lorusso, C Gourley, MR Mirza, JE Kurtz, ...
The Lancet Oncology 23 (8), e374-e384, 2022
502022
Oncologic concerns regarding laparoscopic cytoreductive surgery in patients with advanced ovarian cancer submitted to neoadjuvant chemotherapy
G Favero, N Macerox, T Pfiffer, C Köhler, V da Costa Miranda, ...
Oncology 89 (3), 159-166, 2015
472015
Brazilian Cardio-oncology Guideline–2020
LA Hajjar, IBSS Costa, MACQ Lopes, PMG Hoff, MDPE Diz, ...
Arquivos Brasileiros de Cardiologia 115, 1006-1043, 2020
462020
An international, biomarker-directed, randomized, phase II trial of AZD1775 plus paclitaxel and carboplatin (P/C) for the treatment of women with platinum-sensitive, TP53 …
AM Oza, JI Weberpals, DM Provencher, EM Grischke, M Hall, D Uyar, ...
Journal of Clinical Oncology 33 (15_suppl), 5506-5506, 2015
412015
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer
A Redondo, N Colombo, M McCormack, L Dreosti, A Nogueira-Rodrigues, ...
Gynecologic Oncology 159 (1), 142-149, 2020
352020
The system can't perform the operation now. Try again later.
Articles 1–20